Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool January 24, 2005 Dave Marino-Nachison	J&J Snack Foods Won't Spoil Dinner The SuperPretzel and ICEE company looks like a solid performer that can grow. The stock seems fully valued at current prices and given the market's earnings estimates.
The Motley Fool July 20, 2011	J&J Snack Foods Earnings Preview Investors won't know what to expect for J&J Snack Foods when they report earnings on Monday, as it has wavered between topping and missing analysts estimates during the past fiscal year.
BusinessWeek January 31, 2005 Gene G. Marcial	J & J Snacks: No Belt Tightening Low-carb awareness hasn't softened earnings at J&J Snack Foods, which is big in soft pretzels, frozen drinks, and desserts.
The Motley Fool December 3, 2007 Rick Aristotle Munarriz	4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Disney... J&J Snack Foods... Raymond James Financial... McCormick...
The Motley Fool June 27, 2008 Ryan Fuhrmann	Recession-Proof Stocks: Johnson & Johnson This industry titan's stock is beaten down and should recover quite nicely when headwinds stop working against it and start to shift toward its back.
The Motley Fool August 12, 2010 David Meier	J&J Snack Foods: Deflation Fighter J&J Snack Foods could be a good candidate to keep you ahead of the game.
The Motley Fool January 28, 2011 Anand Chokkavelu	10 Core Stocks: A Johnson & Johnson Update The steady reliability of J&J stock will comfort the core of your portfolio when the market gets a boo-boo.
The Motley Fool May 5, 2004 Seth Jayson	Whole Foods on Fire The biggest retailer of organic and natural foods runs a very tight ship as yesterday's first-quarter numbers show. Whole Foods growth appears phenomenally well managed, and it has been getting better.
The Motley Fool May 2, 2011 Anupama Pattanaik	J&J Attempts to Create Major "Synthes"-is Johnson & Johnson will acquire the medical device maker for $21.3 billion.
The Motley Fool January 24, 2006 Stephen D. Simpson	Shake a Leg, J&J! J&J isn't a perfect story, but investors who buy today and hold for a while will be happy they did.
The Motley Fool September 1, 2005 Stephen D. Simpson	Dull Del Monte Can management capitalize on its valuable brands and growing cash flow? For value-focused investors who can wait it out, Del Monte Foods might be worth a bit of due diligence.
The Motley Fool July 17, 2007 Ryan Fuhrmann	Diagnosing J&J's Product Diversity Health-care giant Johnson & Johnson's blues may indicate trouble ahead for competitors. Investors, take note.
The Motley Fool February 11, 2004 Philip Durell	Mixed Fresh Fruit Salad Fresh Del Monte reports a squeeze on margins, but the stock may still be a bargain.
The Motley Fool November 22, 2006 Brian Lawler	Dueling Fools: Johnson & Johnson Bear Rebuttal The bottom line is that investors are putting their faith in the ability of J&J's management to acquire its way to renewing top-line growth in the coming years.
The Motley Fool August 6, 2004 W.D. Crotty	Dueling Fools: Fresh Del Monte's Ripe Fresh Del Monte is beating the market by five percentage points.
The Motley Fool March 3, 2004 W.D. Crotty	Natural Food Power United Natural Foods is a healthy and growing food distributor.
Prepared Foods July 1, 2005 Marcia Mogelonsky	Conveniently Organic As organic food products become ever more convenient and perceived health benefits persevere, consumers likely will continue to embrace the category's offerings.
The Motley Fool July 28, 2011 Melly Alazraki	J&J or Novartis? Novartis' businesses are an investor's delight; J&J's improving but isn't there yet.
The Motley Fool October 12, 2007 Ryan Fuhrmann	Dueling Fools: Johnson & Johnson Bull The bullish opinion on J&J is that the company is handling current difficulties well, and the low stock price makes for a bargain for investors.
The Motley Fool July 26, 2005 Rich Smith	J&J: One Pricey Stock This giant of the health-care world reported its second quarter 2005 earnings last week but, by all appearances, failed to impress Wall Street. Johnson & Johnson's become very big, very pricey.
The Motley Fool January 26, 2005 Rich Smith	J&J: Dialing for Dollars It pays to be big in a weak dollar world. Just ask Johnson & Johnson. Still, in the year to come, investors will want to keep one eye on J&J's operational performance, and the other on the U.S. Dollar's exchange rates against foreign currencies.
The Motley Fool May 20, 2011 Andrea Kalvesmaki	Johnson & Johnson's Billion-Dollar Move Orthopedics are the name of the game for this company's future earnings.
The Motley Fool November 22, 2006 Brian Lawler	Dueling Fools: Johnson & Johnson Bear J&J's dividend does provide investors with some degree of income, but a CD does, too -- without a health-care stock's risks.
BusinessWeek June 18, 2007 Arlene Weintraub	Johnson & Johnson's Next Baby? J&J could use an infusion of new drugs and devices from an acquisition such as Boston Scientific.
The Motley Fool September 30, 2004 Jeff Hwang	Fresh Del Monte's Bad Blip The company cuts its 2004 earnings outlook by 20%, citing many reasons.
BusinessWeek January 30, 2006 Robert Barker	Guidant Or No, J&J Is A Buy To Wall Street, Johnson & Johnson has been sounding like Dumb & Dumber.
The Motley Fool October 12, 2007 Billy Fisher	Dueling Fools: Johnson & Johnson Bear Rebuttal The bears say that J&J is a good company, but will underperform looking forward.
BusinessWeek April 17, 2006 Amy Barrett	J&J: Reinventing How It Invents Johnson & Johnson bets on a new push for product development as a cure for its ailing stock.
The Motley Fool November 27, 2006 Rick Aristotle Munarriz	4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Hormel... J&J Snack Foods... LCA-Vision... Lancaster Colony...
Food Processing March 2007 Diane Toops	Different is good How these three entrepreneurs turned their dreams into $500 million companies.
The Motley Fool March 4, 2005 W.D. Crotty	Del Monte's Earnings Doldrums Del Monte Foods is still struggling at the bottom line.
The Motley Fool November 22, 2006 Steven Mallas	Dueling Fools: Johnson & Johnson Bull There are many ways to expose one's portfolio to the health-care industry. But J&J offers the best upside potential at relatively little risk.
The Motley Fool October 26, 2011	A Brief History of Johnson & Johnson's Returns J&J shares are much more reasonably valued today than they were ten years ago; shareholders are unlikely to experience the same going forward.
The Motley Fool November 26, 2007 Brian Orelli	Johnson & Johnson Reorganizes -- Who Wins? Johnson & Johnson announces the second phase of its reorganization plan. While it may take years to see whether the measures will help J&J, some other companies could benefit far more quickly.
The Motley Fool August 24, 2010 Matt Koppenheffer	How Much Is Johnson & Johnson Worth? Is Johnson & Johnson's stock on sale?
The Motley Fool December 8, 2005 Stephen D. Simpson	Nuts to Diamond Foods Good nuts and some clever ads don't make for a good buy today, in this investor's view.
The Motley Fool November 15, 2005 Stephen D. Simpson	Guidant, J&J Kiss and Make Up The two companies hammered out a revised merger agreement that continues J&J's buyout of Guidant, but at a lower price. So what does this mean for the med-tech space, assuming that this deal actually goes through? Investors, take note.
The Motley Fool February 25, 2010 Mike Pienciak	Waking Up to Gains The classic consumer name of Smucker's is still going strong.
The Motley Fool January 20, 2004 Alyce Lomax	Is J&J Pain-Free? Fourth-quarter revenues surge, but rivals are waiting in the wings.
The Motley Fool March 24, 2011 Anand Chokkavelu	Rising Star Buy: Johnson & Johnson It's time to buy shares of Johnson & Johnson, the "health-care mutual fund."
The Motley Fool October 17, 2007 Brian Orelli	J&J Puts Band-Aid on the Quarter Investors, Johnson & Johnson's earnings report reads like a one-hit wonder's second album. It goes from good to bad in the blink of an eye -- or in this case, a paragraph or so.
The Motley Fool September 11, 2010 Anand Chokkavelu	How Much of a Bargain Is Johnson & Johnson Stock Right Now? Let's take a look to see how cheap shares of Johnson & Johnson are trading, how consistent its performance has been, and what kind of growth profile it has -- both on an absolute and a relative basis.
BusinessWeek December 20, 2004 Amy Barrett	J&J: Don't Stop Dealmaking Now For years, health-care giant Johnson & Johnson has held on-again, off-again acquisition talks with medical-device maker Guidant Corp. But now, patent expirations and a thin pipeline mean the giant needs more than just Guidant.
The Motley Fool January 12, 2006 Stephen D. Simpson	The Guidant Auction Continues Johnson & Johnson hopes to save the deal with a last-minute raise of its offer. Although Boston Scientific's offer is $4 per share higher, that doesn't necessarily make it the best value. Investors, take note.
The Motley Fool April 21, 2010 Anand Chokkavelu	10 Outperformers Nobody Knows About Yet Take a look at some small-but-mighty outperformers that are flying under the radar of most investors.
BusinessWeek April 23, 2007 Arlene Weintraub	Under The Weather At J&J Johnson & Johnson's three big products have seen setbacks, with little in sight to replace them.
The Motley Fool February 12, 2004 Rick Aristotle Munarriz	Ace in the Whole Foods Whole Foods earns a shiny organic apple for its desk with excellent company performance at a time when other grocers are faltering.
The Motley Fool August 31, 2005 Stephen D. Simpson	United Natural Foods: Healthy Eating, Healthy Stock? Is this natural foods distributor the right ride-along opportunity for investors looking to play the growth of natural foods and healthier living?
The Motley Fool May 2, 2006 Jim Mueller	Foolish Forecast: Whole Foods' Growth, Naturally The Texas-based organic and natural food supermarket reports earnings this Wednesday. Let's take a quick peek at what is expected from this company.
BusinessWeek October 10, 2005	J&J: How A Dealmaker Nurtures Newcomers Johnson & Johnson has a good track record for retaining employees after a takeover. The company's broadly decentralized structure, which gives managers great leeway - no small thing for execs used to running their own shows.